Lazard Asset Management »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $92k 8.8M 0.01

More positions owned by Lazard Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
American Tower Reit (AMT)
Exelon Corporation (EXC)
Crown Castle Intl (CCI)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl C (GOOG)
Canadian Natl Ry (CNI)
Broadcom (AVGO)
Ferrovial Se Ord Shs (FER)
Consolidated Edison (ED)
CSX Corporation (CSX)

View all positions for Lazard Asset Management

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Context Capital Management
Bnp Paribas Arbitrage, Snc
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management
SSI Investment Management
Ing Investment Management
UBS Group

View all funds holding Arrowhead Pharmaceuticals In Note 1/1